- Location: Montreux, Switzerland
- Dates: Wednesday 19th September to Friday 21st September 2018
- Early Bird Price: €875
Normal Price: €1025.
(Early Bird Price available until: Tuesday 1st May 2018)
We are pleased to welcome two new speakers from Novartis and Johnson & Johnson Innovation to the programme for this event. We can announce that Vas Narasimhan, CEO at Novartis will deliver the keynote presentation on Thursday morning.
Participants now have the option of joining one of two additional training workshops being run in parallel to the one-to-one meeting time on Wednesday from 3pm-6pm. The 3-hour training workshops can be booked online at a cost of €100 per person, and will cover:
Workshop A – Financial Evaluation of Licensing Deals
Workshop B – Alliance Management
The XIV IPLS that will take place in the stunning surroundings of Montreux, Switzerland, starting in the afternoon of Wednesday 19th to Friday 21st September 2018.
Montreux is a beautiful one hour and ten minute train journey direct from Geneva Airport, with fantastic scenery as the train skirts around the edge of Lake Geneva.
Train tickets for journeys direct from Geneva Airport to Monteux should be purchased in advance from the SBB website, www.sbb.ch/en, to take advantage of low ticket prices from CHF18 per journey.
Following the success of the online partnering system used during the 2017 event in Madrid, the programme will once again commence on Wednesday afternoon for pre-arranged one-to-one meetings prior the evening drinks reception overlooking Lake Geneva. Partnering and networking will be ongoing throughout the event, with a managed and dedicated one-to-one meeting room available, with extended breaks and a gala dinner on Thursday evening.
The programme will feature 5 sessions, including Deal Case Studies from across the industry (Medical Devices, Biotech, Big Pharma), Regulatory Updates, Opportunities and Market Entry in China, plus the regular look at the Deal Landscape including views and analysis from Evaluate.
Further details will be available shortly.
|3pm - 6pm||Pre-Arranged One-to-One Meetings|
|3pm-6pm||Optional Training Workshops (additional €100 per person)
|Workshop A||Financial Evaluation of Licensing Deals
|Workshop B||Alliance Management
ANTHONY A. HOERNING
Strategic Transactions Advisory
|6pm - 8pm||Welcome Networking Reception|
|9am - 9.30am||Registration|
|Session A||NEW OPPORTUNITIES FOR BD IN A CHANGING WORLD|
|9.30am - 10am||Switzerland - an International Hub for Europe
|10am-10.30am||Brexit and its Consequences for the Pharmaceutical Industry
Director General, B.A.H. (German Medicines Manufacturers' Association)
|10.30am - 11am||Business Opportunities Opening in China
Managing Director and Partner, Head of China Practice, L.E.K. Consulting
|11am 11.30am||Market Entry in China|
|11.30am - 12pm||BREAK|
|SESSION B||NEWS FROM THE REGULATORY & MARKET ACCESS ENVIRONMENT AND THEIR IMPACT ON BD|
|12pm -12.30pm||Market Access Challenges
Head Market Access, Helsinn Healthcare Switzerland
|12.30pm - 1pm||Regulatory Updates on Current Changes and Impact on BD
Partner, Covington & Burling
|1pm - 2pm||LUNCH|
|SESSION C||LESSONS FROM REAL WORLD CASE STUDIES|
|2pm - 2.30pm||Food Supplements
President, FederSalus (Italy)
|2.30pm-3pm||Biotech and Big Pharma Deals
Global Head of Licensing, Servier Monde
|3pm - 3.30pm||Big Pharma to Big Pharma Deals
Senior Director, EMEA Network New Ventures & Transactions, Johnson & Johnson Innovation
|3.30pm - 4pm||Looking Back at the Top Deals - Which Were Truly Successful
ELENA COLUCCELLI-GUERIN Managing Director, Investment Banking, Healthcare, BNP Paribas
Pharma Analyst, Exane BNP Paribas
|4pm - 6pm||Pre-Arranged One-to-One Meetings|
|7pm - 10pm||Networking Reception and Gala Dinner|
|SESSION D||ANALYSING THE HOTTEST DEAL EVOLUTIONS AND NEW DYNAMICS|
|9am - 9.30am||How the Pharma Market is Evolving|
|9.30am - 10am||Current Key Deal Making Trends in Oncology
Managing Director Life Science, Navigant
|10am - 10.30am||Joint Development Agreements and Creative Deal Structures|
|10.30am - 11am||BREAK|
|SESSION E||BACK TO THE FUTURE: HOW CAN WE BUILD A FUTURE WITHOUT LOSING OUR PAST?|
|11am - 11.30am||Designing the Optimal Exit Strategy: IPO, M&A or Dual Track? Featuring Case Studies from Leading Biotech Players in Benelux: Argenx, Galapagos, Ablynx & Ogeda
Executive Director, Corporate Finance, Life Sciences & Healthcare, Kempen
|11.30am - 12pm||Transformational Deals - Deals Which Changed the Business|
|12pm - 12.30pm||Pharma Deals: Which Trends are Driving the Future of Deal Making?
Vice President, European Thought Leadership, IQVIA
|12.30pm - 2pm||LUNCH AND CLOSE|
Fairmont Le Montreux Palace
Avenue Claude Nobs 2
A discounted rate of CHF299 bed & breakfast, per night, is available at the Fairmont Le Montreux Palace for all attendees. This rate can be booked directly with the hotel using the link below. These rates are for Weds 19th – Fri 21st September. For any additional nights or further information please contact email@example.com